Published in Medical Patent Week, April 8th, 2007
Richard Wolf GmbH is one of the world's leading companies in the development and manufacture of endoscopic instruments for diagnostic and therapeutic purposes. The agreement concerns the use of the new WOLF Combilight PDD system in the course of a multi-centre clinical trial investigating the fluorescence-based diagnosis of bladder cancer with PVP hypericin. This highly developed endoscopic technique...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.